Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device

Journal of Clinical Microbiology

Volumn 44, Issue 6, 2006, Pages 2158-2159

  Castle, Philip E ^a   Aftab, Asma ^b   Saint Jean, Gilbert ^b   Mendez, Luis ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ACADEMIC ACHIEVEMENT; ADULT; AFRICAN AMERICAN; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CAUCASIAN; COLPOSCOPY; CYTOPATHOLOGY; DEVICE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS DETECTION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SELF CARE; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA;

HUMAN PAPILLOMAVIRUS;

EID: 33745116580     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02358-05     Document Type: Article

References (9)

1. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
2. 1a. Fournier, A. November 2002. U.S. patent 6,475,165.
3. Guido, R., M. Schiffman, D. Solomon, and L. Burke. 2003. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am. J. Obstet. Gynecol. 188:1401-1405.
4. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
5. Schiffman, M., R. Herrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lorincz. 2000. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 283:87-93.
6. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholder, et al. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
7. Vassilakos, P., S. Griffin, E. Megevand, and A. Campana. 1998. CytoRich liquid-based cervical cytologic test. Screening results in a routine cytopathology service. Acta Cytol. 42:198-202.
8. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
9. Wright, T. C., Jr., M. Schiffman, D. Solomon, J. T. Cox, F. Garcia, S. Goldie, K. Hatch, K. L. Noller, N. Roach, C. Runowicz, and D. Saslow. 2004. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol. 103:304-309.